Corteva Inc

CTVA remains in a Stage 2 advancing regime with a clear uptrend, but the recent Bullish Exhaustion candle at a fresh high and extreme overbought conditions, along with price extended above rising EMAs, make immediate entries unfavorable. We will stalk for a pullback into the 9/21 EMA support zone for potential engagement.

• ↑Q1 revenue $3.6B (+7% YoY) and EBITDA $1.4B (+21% YoY) with 400bp margin gain
• ↑$4.1B 2026 operating EBITDA target underpins longer-term growth
• ↓Negative profitability factors and earnings yield undermine returns